Tsuji explains why JBC paper was retracted: Western blot problems

Last week, we reported on the retraction of a paper in the Journal of Biological Chemistry (JBC) that had one of the journal’s typically inscrutable retraction notices.:

This article has been withdrawn by the authors.

Late last week, we heard back from corresponding author Takashi Tsuji by email. It turns out one of our commenters had basically figured out what was wrong. It was, as seems to often be the case lately in retractions we cover, troubles with Western blots: Continue reading Tsuji explains why JBC paper was retracted: Western blot problems

University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Stefano Fiorucci, a gastroenterology researcher at the University of Perugia in Italy, has been indicted for fraud and embezzlement, after a university investigation found that he had manipulated images in papers that he used to win about 2 million Euros in grant funding.

The case, which has so far resulted in four retractions and nine Expressions of Concern, has dragged on for several years. The trial is scheduled for July. It’s the first time that embezzlement charges have been brought against a scientist found to have committed fraud, according to reports in Umbria 24 and the Umbria Journal.

Fiorucci’s attorney, Stefano Bagianti, told Umbria 24 that there was Continue reading University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma

The authors of a paper published last September in Blood about alleged links between certain genes and Hodgkin’s lymphoma have retracted it, after realizing they’d made mistakes in their calculations.

The retraction notice for “Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups,” dated January 20 and signed by all of the authors, clearly explains what went wrong, taking pains to note that there was no misconduct involved: Continue reading Errors force retraction of Blood paper on genetics of Hodgkin’s lymphoma

PNAS retraction marks second for crystallography group

Two crystallographers who retracted a Structure paper last year have retracted a study about a similar subject in the Proceedings of the National Academy of Sciences, for similar reasons.

Here’s the notice for the paper, which has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading PNAS retraction marks second for crystallography group

Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Following an investigation by the State University of New York (SUNY) Upstate into the work of one of its neuroscientists, the Journal of Neurochemistry has retracted a 2007 paper.

The retraction notice is quite clear about why the paper is being withdrawn: Continue reading Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group

The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why.

This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque: Continue reading Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group

Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

via Wikimedia

Today, without us having planned it, has become the day of retracted papers that found a new home.

This morning, we posted an item about a chimp “culture” paper that was retracted from Biology Letters after its authors found some errors, and then published, with corrections, in the Journal of Human Evolution. This afternoon, we bring you the news of a PLoS ONE paper on longevity genes that is the corrected version of a Science paper retracted last year: Continue reading Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

A mega-correction, but no retraction, in the Journal of Cell Science

In our 2011 year-end post, we promised to keep

…an eye on what may be an emerging trend: The mega-correction. We’ve seen errata notices that correct so many different errors, it’s hard to believe the paper shouldn’t have been retracted. It’s unclear what this means yet, but watch this space for coverage of more examples.

We’ve found another example in the Journal of Cell Science, “Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells,” originally published in September 2011. The correction begins with what turns out to be a bit of an understatement: Continue reading A mega-correction, but no retraction, in the Journal of Cell Science

Authors retract Journal of Cell Science study after realizing they were using the wrong gene constructs

What do you do when it turns out the materials you used in your successful experiment weren’t actually the materials you thought they were?

If you’re Peter Zammit, of King’s College London, and colleagues, you retract a 2008 paper in the Journal of Cell Science. Here’s the notice, for “B-catenin promotes self-renewal of skeletal-muscle satellite cells:” Continue reading Authors retract Journal of Cell Science study after realizing they were using the wrong gene constructs

Journal retracts heart stem cell paper (and pulls no punches) over image fraud

Some retractions beg for a kick of sand in the face, and others do the kicking. Here’s an example of what Charles Atlas might have written had he been a journal editor concerned with research integrity.

Experimental Biology and Medicine, the official journal of the Society for Experimental Biology and Medicine, has retracted a 2010 article by a group of stem cell scientists in China with an unfortunate affinity for a particular figure—one they’d used in a previous publication, only with a different description.

Here’s the notice for the paper, “Isolation and characterization of multipotent progenitor cells from the human fetal aorta wall,” which was cited five times before it was retracted, according to Thomson Scientific’s Web of Knowledge: Continue reading Journal retracts heart stem cell paper (and pulls no punches) over image fraud